Qualigen Therapeutics, Inc. — Director's Dealing 2017

Feb 1, 2017

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: RITTER PHARMACEUTICALS INC (RTTR)
CIK: 0001460702
Period of Report: 2017-01-17

Reporting Person: Merino William M. (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1398	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Non-Qualified Stock Option (Right to Buy	$2.25	2025-10-13	Common Stock (2000)		Direct

Footnotes

F1: 25% of the shares underlying the option vested on 7/10/2016. 1/36th of the remainder have vested (or will vest) on the 10th day of each calendar month thereafter.